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Abstract
Rationale: Chorioamnionitis and antenatal glucocorticoids are common exposures for preterm infants and can affect
the fetal brain, contributing to cognitive and motor deficits in preterm infants. The effects of antenatal glucocorticoids
on the brain in the setting of chorioamnionitis are unknown. We hypothesized that antenatal glucocorticoids would
modulate inflammation in the brain and prevent hippocampal and white matter injury after intra-amniotic
lipopolysaccharide (LPS) exposure.
Methods: Time-mated ewes received saline (control), an intra-amniotic injection of 10 mg LPS at 106d GA or 113d
GA, maternal intra-muscular betamethasone (0.5 mg/kg maternal weight) alone at 113d GA, betamethasone at 106d
GA before LPS or betamethasone at 113d GA after LPS. Animals were delivered at 120d GA (term=150d). Brain
structure volumes were measured on T2-weighted MRI images. The subcortical white matter (SCWM), periventricular
white matter (PVWM) and hippocampus were analyzed for microglia, astrocytes, apoptosis, proliferation, myelin and
pre-synaptic vesicles.
Results: LPS and/or betamethasone exposure at different time-points during gestation did not alter brain structure
volumes on MRI. Betamethasone alone did not alter any of the measurements. Intra-amniotic LPS at 106d or 113d
GA induced inflammation as indicated by increased microglial and astrocyte recruitment which was paralleled by
increased apoptosis and hypomyelination in the SCWM and decreased synaptophysin density in the hippocampus.
Betamethasone before the LPS exposure at 113d GA prevented microglial activation and the decrease in
synaptophysin. Betamethasone after LPS exposure increased microglial infiltration and apoptosis.
Conclusion: Intra-uterine LPS exposure for 7d or 14d before delivery induced inflammation and injury in the fetal
white matter and hippocampus. Antenatal glucocorticoids aggravated the inflammatory changes in the brain caused
by pre-existing intra-amniotic inflammation. Antenatal glucocorticoids prior to LPS reduced the effects of intra-uterine
inflammation on the brain. The timing of glucocorticoid administration in the setting of chorioamnionitis can alter
outcomes for the fetal brain.
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Introduction
Preterm birth (before 37 weeks of gestation) is associated
with chorioamnionitis, an infection/inflammation of the amniotic
fluid and placental membranes, which is present in up to 60%
of early gestation preterm births [1,2]. Exposure to intra-uterine
inflammation is associated with adverse effects on fetal lung
[3,4], gut [5,6] and brain [7] development and increases the risk
for complications in postnatal life [8]. Administration of
antenatal glucocorticoids to induce fetal lung maturation has
become standard of care for mothers at risk of preterm
delivery, irrespective of the cause of preterm birth [9,10]. As
chorioamnionitis is often clinically silent prior to preterm labor,
combined exposures to antenatal glucocorticoids and
chorioamnionitis are very common in preterm fetuses.
There is a clear relationship between the presence of
chorioamnionitis and the development of neurological
complications in preterm infants [11,12]. Exposure to intra-
uterine inflammation can lead to intraventricular hemorrhage
and white matter injury (WMI) which can manifest clinically as
periventricular leukomalacia (PVL), cerebral palsy (CP) [13,14]
and an increased risk for other adverse neurodevelopmental
complications such as cognitive impairments [15], autism
spectrum disorders [16,17] and schizophrenia [18,19]. Animal
models of intra-uterine inflammation have helped to reveal
some of the molecular mechanisms underlying fetal brain injury
[20-22]. Chronic intra-amniotic administration of
lipopolysaccharide (LPS) to fetal sheep induced microglial
activation and white matter injury in the subcortical white matter
(SCWM) [23]. Gavilanes et al. showed that a single intra-
amniotic bolus of LPS resulted in microglial activation,
astrocyte proliferation and increased apoptosis in the ovine
fetal brain, which were associated with functional changes in
EEG after preterm birth [24].
The effects of intra-uterine inflammation are not limited to the
brain [8]. We showed that intra-amniotic LPS induced lung
inflammation and activation of the fetal immune system in
sheep [25-27]. Antenatal glucocorticoid administration before or
after the LPS exposure attenuated inflammation and injury in
the lung and reduced the fetal immune response [25,28]. In the
current study, we hypothesized that antenatal glucocorticoids
would modulate inflammation in the fetal near term brain and
prevent subsequent hippocampal and white matter injury after
intra-amniotic LPS exposure. For this purpose, fetal sheep
were exposed to intra-amniotic LPS at 2 different gestational
ages (GA) before preterm delivery to investigate the acute and
persistent effects of the exposures on the near term brain. The
effect of antenatal glucocorticoid treatment was evaluated by
administration of maternal betamethasone before the LPS
exposure (i.e. betamethasone pre-treatment) to model the
clinical situation for women who present with preterm labor and
receive glucocorticoid treatment prior to the infectious
exposure, often following rupture of membrane. We also gave
betamethasone after the LPS exposure (i.e. betamethasone
post-treatment) at 7-day intervals as a representative of the
clinical scenario of women in preterm labor due to chronic
indolent chorioamnionitis which then receive antenatal
glucocorticoids. An interval of 7 days between the two
exposures was chosen as representative of the period between
recognition of preterm labor and the actual preterm delivery [1]
and the repeated administration of antenatal glucocorticoids at
weekly intervals [29].
Materials and Methods
Animal study
All studies were approved by the Animal Ethics Committees
at The University of Western Australia and Cincinnati
Children`s Hospital Medical Center (animal ethics protocol RA/
3/100/830). The experimental design of this animal study was
published previously [26]. Briefly, time-mated ewes with
singleton fetuses were exposed to LPS (intra-amniotic injection
(IA) of 10 mg LPS Escherichia Coli, 055:B5 Sigma-Aldrich, St.
Louis, MO, USA) to induce intra-amniotic inflammation and/or
maternal betamethasone (intra-muscular injection (IM) of
betamethasone as Celestone Soluspan, Schering-Plough,
North Ryde, New South Wales, Australia at a dose of 0.5
mg/kg maternal weight which has been demonstrated to induce
lung responses in sheep [30,31]) either at 106d GA or 113d
GA. The following are the treatment groups: IA LPS at 113d
GA (7d LPS group; n=7), IM betamethasone at 113d GA (7d
Beta group; n=6), IM betamethasone at 106d GA followed by
IA LPS at 113d GA (Beta-Pre + 7d LPS group; n=6), IA LPS at
106d GA (14d LPS group; n=7) or IA LPS at 106d GA followed
by IM betamethasone at 113d GA (14d LPS + Beta-Post group;
n=6). Control animals were exposed to IA saline and IM saline
at 106d and 113d GA (Table 1).
Table 1. Experimental treatment groups.
 Injection at 106d GA   Injection at 113d GA   Number of animals
Control IA saline IM saline 4
7d LPS - IA LPS 7
7d Beta - IM Beta 6
Beta-Pre + 7d LPS IM Beta IA LPS 6
14d LPS IA LPS - 7
14d LPS + Beta-Post IA LPS IM Beta 6
IA: intra-amniotic; IM: intra-muscular; GA: gestational age; Beta: betamethasone; LPS: lipopolysaccharide; Beta-Pre: betamethasone pre-treatment; Beta-Post:
betamethasone post-treatment.
doi: 10.1371/journal.pone.0081644.t001
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As betamethasone can induce preterm delivery in sheep, all
ewes also received a single intra-muscular injection of
medroxyprogesterone acetate (Depo-Provera 150 mg, Kenral,
New South Wales, Australia) at 100 days GA to decrease the
risk of preterm labor. Lambs were delivered by caesarean
section at 120d GA (term = 150d GA) and euthanized at birth
by an intra-venous injection of 100 mg/kg pentobarbital. The
gestational age of 120 days is comparable to a near term infant
in terms of brain development [22,32,33]. Animal
characteristics and cord blood values at birth were reported
previously and did not differ between groups [26]. The fetal
brain was perfusion-fixed via the carotid arteries in 0.1M
phosphate buffer (pH 7.4) and with 4% paraformaldehyde at
4°C for 24 hours and then stored in 30% sucrose at 4°C.
MRI analysis
After perfusion fixation, anatomical T2-weighted images of
the fetal brains in the skull were acquired using a 7 Tesla
Bruker Biospin 70/30 USR scanner (Bruker, Ettlingen,
Germany). After optimization all T2-weighted images were
acquired using spin-echo sequences with the following
parameters: (TR=2000 and TE=78 ms), with an isovolumetric
voxel size of 200 µm3 and no gap. The field of view (FOV) was
55x70x45 mm and scan matrix size 275x512x225 mm.
MRI data were processed using the MIPAV software
package (Medical Image Processing, Analysis, and
Visualization, version 5.2.1; National Institutes of Health),
which enables quantitative analysis and visualization of
medical images. A blinded observer measured size and volume
of several brain structures in T2-weighted images on fixation
artefact free slices. Measurements included: (1) mid-sagittal
antero-posterior brain diameter (mm), (2) mid-sagittal cranio-
caudal diameter of the cerebellum (mm), (3) mid-sagittal
antero-posterior diameter of the pons (mm) (4), mid-sagittal
antero-posterior length of the corpus callosum (mm) (5), mid-
sagittal volume of the corpus callosum (mm3) and (6) maximal
parasagittal volume of thalamus (mm3) (Figure 1).
Immunohistochemistry
For immunohistochemistry of the fetal brain, tissue from the
right hemisphere was embedded in 10% gelatin. Serial coronal
sections, with a thickness of 50 µm to maintain the cellular
morphology [34], were cut on a vibrotome (Leica Biosystems,
Nussloch, Germany). Sections were stained by free-floating
techniques as described previously [34] for ionized calcium
binding adaptor molecule 1 (IBA1, #019-19741, Wako Pure
Chemical Industries, Osaka, Japan), glial fibrillary acidic protein
(GFAP, Z0334, Dakocytomation, Glostrup, Denmark) cleaved
caspase-3 (Asp175, #9661S, Cell Signaling Technology,
Boston, USA), Ki67 (M7240, Dakocytomation), myelin basic
protein (MBP, MAB386, Merck Millipore, Billerica, MA, USA)
and synaptophysin (MAB5258, Merck Millipore). Briefly,
sections were rinsed with Tris buffered saline (TBS, pH 7.6)
and TBS-Triton (TBS-T, pH 7.6). Endogenous peroxidase
activity was blocked by incubating in 0.3% H2O2 in TBS. Next,
the sections were incubated overnight at 4°C with the diluted
primary antibody (IBA1 1:1000, GFAP 1:2000, cleaved
caspase-3 1:800, Ki67 1:100, MBP 1:2000, synaptophysin
1:2000 with 0.3% donkey serum). After rinsing, a secondary
donkey-anti-rabbit (IBA1, GFAP, cleaved caspase-3), donkey-
anti-mouse (synaptophysin, Ki67) or donkey-anti-rat (MBP)
biotin labeled antibody was added for incubation in room
temperature for 2 hours. The immunostaining was enhanced
with Vectastain ABC peroxidase Elite kit (PK-6200, Vector
Laboratories, Burlingame, USA) followed by nickel sulfate-
diaminobenzidine. The stained sections were mounted on
gelatin-coated glass slides, dehydrated and coverslipped.
Quantification
For the analysis of IBA1 and GFAP immuno-reactivity in the
hippocampus, one digital image per coronal section (n=5
sections per animal) of the dentate gyrus (DG), cornu ammonis
(CA)1/2, CA3 and CA4 were acquired at 100x magnification
with an Olympus AX-70 microscope connected to a digital
camera (F-view, Olympus, Tokyo, Japan). In the SCWM and
PVWM two images per coronal section (n=5 sections per
animal) were obtained on a standardized location within these
regions of interest. All images were collected under the same
lighting conditions. The area fraction (%) of IBA1 or GFAP
immuno-reactivity was measured by applying a standard
threshold using a specifically designed algorithm in Leica QWin
Pro V 3.5.1 software (Leica, Rijswijk, the Netherlands) [34].
To measure the density (cells per mm2) of Ki67-positive cells
and cleaved caspase-3 positive cells, digital images of the
hippocampus (4 images), PVWM (2 images) and SCWM (2
images) in the standardized regions described above on 5
consecutive coronal sections per animal were taken at 200x
magnification with the same microscope and digital camera as
above. Ki67-positive cells were counted using Image J
software (Rasband, W.S., Image J US National Institutes of
Health, Bethesda, Maryland, USA). The density (cells per mm2)
of cleaved caspase-3 positive cells in the PVWM and SCWM
were similarly measured. For the analysis in the hippocampus,
the area fraction (%) of cleaved caspase-3 immuno-reactivity
was measured using Leica QWin Pro V 3.5.1 software, since
the hippocampus is densely populated with overlapping
cleaved caspase-3 positive cells that could not be distinguished
as single cells [35].
For the analysis of MBP and synaptophysin, digital images
from the SCWM (2 images) for MBP and from the
hippocampus (2 images in CA1/2 region, 2 images in CA3, 1
image in CA4 and DG) for the synaptophysin staining on 5
consecutive coronal sections per animal were acquired
similarly at 200x magnification. In the PVWM no MBP immuno-
reactivity was detected because of the developmental timing of
appearance of late oligodendrocyte progenitor cells expressing
MBP in the PVWM of sheep and humans [34,36,37]. The area
fraction (%) of MBP and synaptophysin immuno-reactivity was
measured using Leica QWin Pro V 3.5.1 software. All analyses
were performed by a blinded observer.
Data analysis
Data are expressed as mean ± SEM. Groups which were
exposed at the same gestational age were compared using
one-way ANOVA with Tukey or Dunnett’s tests for post-hoc
analysis or by a non-parametric Kruskal-Wallis test as
Glucocorticoids, Inflammation and the Fetal Brain
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appropriate. Statistical analysis was performed by GraphPad
Prism v5.0. Significance was accepted at p<0.05.
Results
MRI measurements
T2-weighted MRI images were used to measure anatomical
variables such as brain diameter, cerebellum and pons
diameter, corpus callosum (CC) length and CC and thalamus
volume (Figure 1). Exposure to intra-amniotic LPS and/or
maternal antenatal glucocorticoids either 7 or 14 days before
delivery did not significantly alter any of the measurements in
the fetal brain compared to control animals (Table 2).
Fetal exposure to intra-amniotic LPS and/or antenatal
glucocorticoids 7 days before delivery
Brain inflammation was investigated by measuring the area
fraction (%) of IBA1 and GFAP as markers for microglial and
astrocyte infiltration respectively, in the fetal hippocampus,
subcortical white matter and periventricular white matter.
Apoptosis was assessed by immunohistochemical staining for
cleaved caspase-3, proliferating cells were identified by Ki67
staining, myelination and late oligodendrocyte progenitor cells
shown by MBP [36] and pre-synaptic vesicle density was
assessed by synaptophysin staining.
Exposure to intra-amniotic LPS 7 days before delivery
increased IBA1 immuno-reactivity in the hippocampus (Figure
2A), SCWM (Figure 3A) and PVWM (Figure 4A). Microglia of
LPS exposed animals (Figure 2C, 3C) showed several
Figure 1.  Brain volumes measured with MRI images.  The mid-sagittal antero-posterior brain diameter (mm) (1), mid-sagittal
cranio-caudal diameter of the cerebellum (mm) (2), mid-sagittal antero-posterior diameter of the pons (mm) (3), mid-sagittal antero-
posterior length of the corpus callosum (mm) (4), mid-sagittal volume of the corpus callosum (mm3) (5) and maximal parasagittal
volume of thalamus (mm3) (6) of the ovine fetal brain were measured on T2-weighted MRI images.
doi: 10.1371/journal.pone.0081644.g001
Glucocorticoids, Inflammation and the Fetal Brain
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morphological changes such as hypertrophic cell bodies and
thickened shortened processes compared to controls (Figure
2B, 3B). GFAP immuno-reactivity increased significantly in all
investigated brain regions in 7d LPS exposed animals (Figure
2E, 3E, 4B). Compared to controls (Figure 2F, 3F), GFAP-
positive cells in the LPS exposed animals (Figure 2G, 3G)
showed enlarged cell bodies and retracted processes
suggesting active gliosis. Exposure to LPS 7 days before
delivery increased apoptosis in the fetal hippocampus and
PVWM compared to controls (Table 3) and significantly
decreased the hippocampal area fraction (%) of synaptophysin
immuno-reactivity (Figure 2I). LPS exposed animals (Figure
2K) showed a clear reduction in synaptophysin immuno-
reactivity in the fetal hippocampus compared to controls
(Figure 2J). Ki67 (Table 3) and MBP expression (Figure 3I) did
not differ between 7d LPS exposed animals and control
animals in the investigated brain regions.
Betamethasone pre-treatment at 106 days gestational age
before intra-amniotic LPS exposure at 113 days gestational
age (Beta-Pre + 7d LPS) reduced IBA1 immuno-reactivity in
the fetal hippocampus (Figure 2D) and SCWM (Figure 3D)
compared to 7d LPS exposed animals. Betamethasone pre-
treatment before the LPS exposure normalized synaptophysin
immuno-reactivity (Figure 2I) in the hippocampus but did not
prevent the LPS-induced increase in GFAP immuno-reactivity
in the investigated regions of the fetal brain (Figure 2H, 3H, 4B)
nor did it prevent increased hippocampal apoptosis (Table 3).
Fetal exposure to intra-amniotic LPS and/or antenatal
glucocorticoids 14 days before delivery
Exposure to intra-amniotic LPS 14 days before delivery (14d
LPS) increased IBA1 immuno-reactivity in the PVWM and
GFAP immuno-reactivity in all investigated regions (Figure 5E,
6E, 7) compared to control animals, with morphological
changes consistent with activation of microglia and astrocytes
(Figure 5C). Animals exposed to LPS 14 days before delivery
showed reduced hippocampal synaptophysin expression
(Figure 5I) and less MBP immuno-reactivity and loss of MBP-
positive cells in the SCWM (Figure 6I) compared to control
animals indicating grey and white matter injury. Proliferation
rates were decreased and apoptosis was increased in the
hippocampus in 14d LPS exposed animals compared to
controls (Table 3).
Animals that received betamethasone post-treatment 7 days
after the LPS exposure (14d LPS + Beta-Post) showed
increased IBA1 immuno-reactivity in the fetal hippocampus
compared to animals exposed to LPS only (Figure 5D).
Betamethasone post-treatment decreased hippocampal GFAP
immuno-reactivity which was induced by the LPS exposure
(Figure 5H) and normalized hippocampal synaptophysin
expression (Figure 5L). LPS-induced white matter injury was
not prevented by Betamethasone post-treatment and was still
evident in the 14d LPS + Beta-Post animals (Figure 6L) with
decreased MBP immuno-reactivity in the SCWM. When
exposed to both LPS and Betamethasone post-treatment,
animals showed increased numbers of Ki67-positive cells in the
hippocampus and SCWM and increased apoptosis in the
PVWM and SCWM compared to animals exposed to LPS only
(Table 3). Betamethasone post-treatment did decrease the
LPS-induced apoptosis in the fetal hippocampus (Table 3).
Discussion
We investigated the effects of intra-uterine inflammation and
antenatal glucocorticoids, two common antenatal exposures for
preterm infants at two different time point in gestation, on the
ovine fetal brain. Intra-amniotic LPS exposure either at 106d
(14d LPS exposure) or 113d GA (7d LPS exposure) before
preterm delivery at 120d GA induced a cerebral inflammatory
response with hippocampal and white matter injury.
Glucocorticoid treatment in the absence of intra-uterine
inflammation did not affect the fetal brain. Antenatal maternal
glucocorticoids administered with pre-existing intra-amniotic
inflammation aggravated the LPS-induced inflammatory
changes in the fetal brain. Antenatal glucocorticoids given prior
to LPS reduced the effects of intra-uterine inflammation on the
fetal brain. Although this study only describes the interactive
effects of LPS and glucocorticoids at two different time-points
during gestation, these findings do identify differential effects of
these two common exposures on the fetal near term brain.
Our findings did not show any harmful effects of antenatal
glucocorticoid treatment in the absence of intra-uterine
inflammation on the fetal brain. Although antenatal
glucocorticoids reduce the risk of intraventricular hemorrhage
Table 2. Brain volumes measured with MRI images.
 Control (n=4)   7d Beta (n=6)   7d LPS (n=7)   Beta-Pre + 7d LPS (n=6)   14d LPS (n=7)   
14d LPS + Beta-Post
(n=7)
Brain (mm) (mid-sagittal antero-posterior) 20.0±1.1 18.4±0.9 23.4±3.7 18.4±0.7 19.2±0.7 22.5±0.5
Cerebellum (mm) (mid-sagittal cranio-caudal) 8.7±05 8.2±0.4 10.2±1.9 9.0±0.6 8.5±0.2 10.1±0.2
Pons (mm) (mid-sagittal antero-posterior) 2.3±0.2 2.2±0.1 2.7±0.4 2.3±0.1 2.3±0.1 2.8±0.1
Corpus callosum (mm) (mid-sagittal antero-posterior) 8.1±0.3 7.9±0.2 11.2±2.3 8.0±0.6 7.9±0.4 9.2±0.4
Corpus callosum (mm3)(mid-sagittal) 2.8±0.4 2.7±0.2 4.2±1.3 2.7±0.2 3.1±0.2 3.1±0.1
Thalamus (mm3) (maximal parasagittal) 8.5±1.4 8.9±0.8 12.1±2.6 10.1±0.7 9.4±0.6 9.3±0.5
Data corrected for body weight and expressed as mean ± SEM. LPS: lipopolysaccharide; Beta-Pre: betamethasone pre-treatment; Beta-Post: betamethasone post-
treatment.
doi: 10.1371/journal.pone.0081644.t002
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and periventricular leukomalacia [9,38], there are concerns
about the effects of glucocorticoids on fetal brain development,
in particular on brain growth [39,40], neurogenesis [41,42] and
myelination [43]. Recently, Tijsseling et al. [44] showed
reduced histological neuronal density in the hippocampus of
neonates after antenatal glucocorticoid treatment. In animal
models multiple doses of antenatal glucocorticoids at different
time points during gestation can modulate apoptotic rates [45].
Furthermore, repeated doses of antenatal glucocorticoids
decrease the expression of cytoskeletal proteins microtubule-
associated protein (MAP)1B and MAP2 and synaptophysin
expression in fetal sheep brain suggesting functional
disturbances in the neuronal network [46,47]. Although it is less
clear how a single course of antenatal glucocorticoids affects
the developing brain, in clinical practice the beneficial effects of
glucocorticoids on lung maturation and consequent neonatal
survival outweigh these concerns.
We used T2-weighted MRI imaging to investigate volumetric
changes in the ovine fetal brain. The MRI imaging did not
detect any gross volumetric changes after exposure to intra-
amniotic LPS which is in line with previous clinical findings
[48,49]. Acute (7d before delivery) or persistent (14d before
delivery) exposure to intra-uterine inflammation induced an
inflammatory response in the brain regions we investigated as
indicated by increased microglia and astrogliosis associated
with hypomyelination and reduced synaptophysin expression.
We did not monitor brain function, but microglial activation and
apoptosis in the white matter of preterm lambs exposed to LPS
Figure 2.  Hippocampal changes after intra-amniotic LPS exposure and antenatal glucocorticoids 7 days before
delivery.  A: The area fraction (%) of IBA1 immuno-reactivity increased significantly after intra-amniotic LPS exposure 7 days
before delivery. B-D: Representative images of the IBA1 staining in the CA1 region of the hippocampus in controls (B), 7d LPS (C)
and Beta-Pre + 7d LPS (D) exposed animals. E: Intra-amniotic LPS exposure significantly increased the hippocampal area fraction
(%) of GFAP immuno-reactivity. F-H: Representative images of the GFAP staining in the CA1 region of the hippocampus in controls
(F), 7d LPS (G) and Beta-Pre + 7d LPS (H) exposed animals. I: The area fraction (%) of synaptophysin immuno-reactivity
decreased 7 days after intra-amniotic LPS exposure compared to controls. J-L: Representative images of the synaptophysin
staining in the CA1 region of the hippocampus in controls (J), 7d LPS (K) and Beta-Pre + 7d LPS (L) exposed animals. Scale bar =
200 µm; scale bar insert = 25 µm. *p<0.05 versus controls and § p<0.05 between experimental groups using a one-way ANOVA
with Tukey’s post hoc test.
doi: 10.1371/journal.pone.0081644.g002
Glucocorticoids, Inflammation and the Fetal Brain
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correlated with increased EEG delta frequency which was
associated with seizure disorders [24,50]. Studies of Dean et
al.[51] and Keogh et al.[52] support these findings by showing
that inflammatory changes in the ovine fetal brain correlated
with loss of the normal maturational increase in the EEG
amplitude. Furthermore, our findings of decreased pre-synaptic
vesicle density in the fetal hippocampus suggest that synaptic
transmission was compromised after LPS exposure [53].
We investigated the effect of the timing of combined
exposures of the ovine near term brain to intra-amniotic
inflammation and antenatal glucocorticoids, since
glucocorticoids can have both pro- and anti-inflammatory
properties in the presence of inflammation [54]. Antenatal
glucocorticoids are administered when preterm birth is
imminent irrespective of the cause of preterm birth [9].
However, there is a lack of knowledge concerning the use of
antenatal glucocorticoids in the settings of intra-uterine
infections [9]. Kallapur et al. [55] previously showed that
combined maternal betamethasone and intra-amniotic LPS
exposure increased fetal lung inflammation compared to LPS
exposure alone suggesting that glucocorticoids alter the
immune response of the preterm lung to inflammation. In this
model antenatal exposure to glucocorticoids either before or
after an inflammatory challenge has contrasting effects on the
fetal immune response [25,26] and subsequent brain
inflammation and injury. Antenatal glucocorticoid administration
Figure 3.  Effect of intra-amniotic LPS and antenatal glucocorticoid exposure 7 days before delivery on the subcortical
white matter.  A: The area fraction (%) of IBA1 immuno-reactivity in the subcortical white matter increased significantly after intra-
amniotic LPS exposure 7 days before delivery. B-D: Representative images of the IBA1 staining in the SCWM in controls (B), 7d
LPS (C) and Beta-Pre + 7d LPS (D) exposed animals. E: LPS exposure 7 days before delivery significantly increased the area
fraction (%) of GFAP immuno-reactivity in the SCWM. F-H: Representative images of the GFAP staining in the SCWM in controls
(F), 7d LPS (G) and Beta-Pre + 7d LPS (H) exposed animals. I: The area fraction (%) of MBP immuno-reactivity did not differ in
animals exposed to intra-amniotic LPS and/or betamethasone exposure 7 days before delivery. J-L: Representative images of the
MBP staining in the SCWM in controls (J), 7d LPS (K) and Beta-Pre + 7d LPS (L) exposed animals. Scale bar = 200 µm; scale bar
insert = 25 µm. *p<0.05 versus controls and § p<0.05 between experimental groups using a one-way ANOVA with Tukey’s post hoc
test.
doi: 10.1371/journal.pone.0081644.g003
Glucocorticoids, Inflammation and the Fetal Brain
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before the LPS exposure prevented inflammation in the fetal
lung, thymus and brain whereas glucocorticoid administration
after the LPS exposure aggravated inflammation in the fetal
organs [25,26]. Although the anti-inflammatory actions of
glucocorticoids have been recognized for several decades,
recent studies suggest that glucocorticoids can also have pro-
inflammatory properties [54,56]. The balance of these pro- and
anti-inflammatory effects depends on which phase of the
immune response the glucocorticoids are administered.
Glucocorticoid-mediated activation of the glucocorticoid
receptor induces suppression of transcriptional activity of NF-
ĸB and other genes involved in the inflammatory response
[57,58]. Therefore pre-treatment with glucocorticoids inhibits
the subsequent inflammatory response initiated by LPS-
mediated Toll-like receptor signaling, resulting in anti-
inflammatory immunological response. However, when the
inflammatory response is initiated before activation of the
glucocorticoid receptor, the immune response may shift to pro-
inflammatory as glucocorticoids can enhance the expression of
Toll-like receptors and consequently increase pro-inflammatory
Figure 4.  Periventricular white matter changes after intra-amniotic LPS and antenatal glucocorticoids 7 days before
delivery.  A: The area fraction (%) of IBA1 immuno-reactivity in the PVWM increased significantly in animals exposed to intra-
amniotic LPS 7 days before delivery irrespective of the betamethasone pre-treatment. B: LPS exposure 7 days before delivery
significantly increased the area fraction (%) of GFAP immuno-reactivity Irrespective of betamethasone pre-treatment. *p<0.05
versus controls using a one-way ANOVA with Tukey’s post hoc test.
doi: 10.1371/journal.pone.0081644.g004
Table 3. Antenatal glucocorticoid treatment modulates the LPS-induced effects on apoptosis and proliferation in the fetal
brain.
 Control 7d Beta 7d LPS Beta-Pre + 7d LPS 14d LPS 14d LPS + Beta-Post
Ki67 (cells/mm2)
Hippocampus 126±8 136±11 91±8 135±21 58±6* 145±7£
PVWM 71±9 71±11 54±5 55±15 66±10 70±6
SCWM 80±7 95±11 49±6 71±10 58±7 87±5£
Cleaved caspase-3
Hippocampus (%stained area) 6.3±0.7 7.9±0.6 13.2±1.1* 10.9±1.0* 12.6±0.9* 9.8±0.7*£
PVWM (cells/mm2) 325±30 296±31 463±34* 317±35§ 269±20 482±43*£
SCWM (cells/mm2) 94±13 152±12 137±17 121±13 138±13 201±21*£
Data expressed as mean ± SEM. LPS: lipopolysaccharide; Beta-Pre: betamethasone pre-treatment; Beta-Post: betamethasone post-treatment. * p<0.05 versus controls; §
p<0.05 versus 7d LPS; £ p<0.05 versus 14d LPS
doi: 10.1371/journal.pone.0081644.t003
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cytokine production [59,60]. Consequently, the timing of
exposure to anti- and pro-inflammatory stimuli appears to be
essential in determining the eventual outcome of the immune
response, not only in vitro, but also in vivo in the fetus.
There are limitations to this study. We were not able to
identify which cells in the fetal brain underwent apoptosis or
loss of proliferation after the exposures. Furthermore, we did
not assess what the effects of these histological changes were
on the functional outcome of the fetal brain. However, recent
studies have shown that minor changes in the activation state
of microglia or moderate white matter damage can affect EEG
maturation in the fetal brain suggesting that even low grade
inflammation/injury as seen in this study can impact fetal brain
function [24,51,52]. The animals in this study were exposed to
intra-amniotic LPS and maternal glucocorticoids either 7 days
or 14 days before preterm delivery. However, exposures at
different time points, for different intervals and to a single dose
or repeated doses of glucocorticoids during fetal development
may have different outcomes. Although our study does not
identify new concerns for the use of a single dose of
glucocorticoids, long term effects of antenatal glucocorticoid
treatment on neonatal neurodevelopment remain unclear.
In conclusion, we have shown that intra-amniotic LPS
exposure either at 106d GA or 113d GA induced inflammation
and injury in the regions of the ovine near term brain that we
evaluated and without volumetric changes measured by MRI.
Figure 5.  Hippocampal changes after intra-amniotic LPS exposure and antenatal glucocorticoids 14 days before
delivery.  A: The area fraction (%) of IBA1 immuno-reactivity increased after exposure to intra-amniotic LPS exposure followed by
Betamethasone post-treatment. B-D: Representative images of the IBA1 staining in the CA1 region of the hippocampus in controls
(B), 14d LPS (C) and 14d LPS + Beta-Post (D) exposed animals. E: Intra-amniotic LPS exposure increased GFAP immuno-
reactivity in the hippocampus. F-H: Representative images of the GFAP staining in the CA1 region of the hippocampus in controls
(F), 14d LPS (G), and 14d LPS + Beta-Post (H) exposed animals. I: The area fraction (%) of synaptophysin immuno-reactivity
decreased 14 days after intra-amniotic LPS exposure compared to controls. J-L: Representative images of the synaptophysin
staining in the CA1 region of the hippocampus in controls (J), 14d LPS (K) and 14d LPS + Beta-Post (L) exposed animals. Scale
bar = 200 µm; scale bar insert = 25 µm. *p<0.05 versus controls and § p<0.05 between experimental groups using a one-way
ANOVA with Tukey’s post hoc test.
doi: 10.1371/journal.pone.0081644.g005
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Our findings demonstrate that maternal antenatal
betamethasone administration can increase the inflammatory
changes in the fetal brain caused by pre-existing intra-amniotic
inflammation suggesting that when a fetus is exposed to
chorioamnionitis, the brain may sustain additional injury after a
secondary exposure to maternal glucocorticoids. Antenatal
glucocorticoids given prior to intra-amniotic inflammation
reduced the cerebral inflammatory response after intra-
amniotic LPS and prevented hippocampal and white matter
injury in the fetal brain. This study shows that the timing of
treatment with maternal glucocorticoids in the setting of intra-
uterine inflammation determines the effects on the near term
fetal brain. Therefore, future experimental studies should focus
on the immuno-modulatory effects of antenatal glucocorticoid
treatment at the onset of chorioamnionitis.
Figure 6.  Effect of intra-amniotic LPS and antenatal glucocorticoid exposure 14 days before delivery on the subcortical
white matter.  A: The area fraction (%) of IBA1 immuno-reactivity did not change after intra-amniotic LPS and/or betamethasone
exposure 14 days before delivery. B-D: Representative images of the IBA1 staining in the SCWM in controls (B), 14d LPS (C) and
14d LPS + Beta-Post (D) exposed animals. E: LPS exposure 14 days before delivery significantly increased the area fraction (%) of
GFAP immuno-reactivity irrespective of betamethasone post-treatment. F-H: Representative images of the GFAP staining in the
SCWM in controls (F), 14d LPS (G) and 14d LPS + Beta-Post (H) exposed animals. I: The area fraction (%) of MBP immuno-
reactivity decreased 14 days after intra-amniotic LPS exposure irrespective of betamethasone treatment compared to controls. J-L:
Representative images of the MBP staining in the SCWM in controls (J), 14d LPS (K) and 14d LPS + Beta-Post (L) exposed
animals. Scale bar = 200 µm; scale bar insert = 25 µm. *p<0.05 versus controls using a one-way ANOVA with Tukey’s post hoc test.
doi: 10.1371/journal.pone.0081644.g006
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Figure 7.  Periventricular white matter changes after intra-amniotic LPS and antenatal glucocorticoids 14 days before
delivery.  A: The area fraction (%) of IBA1 immuno-reactivity in the PVWM increased after intra-amniotic LPS exposure 14 days
before delivery irrespective of the betamethasone post-treatment. B: LPS exposure 14 days before delivery increased the area
fraction (%) of GFAP immuno-reactivity. *p<0.05 versus controls using a one-way ANOVA with Tukey’s post hoc test.
doi: 10.1371/journal.pone.0081644.g007
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